Page last updated: 2024-11-05

peracetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Peracetic acid (PAA) is a colorless liquid with a pungent odor. It is a strong oxidizer and is produced by the reaction of hydrogen peroxide with acetic acid in the presence of a catalyst. It is commonly used as a disinfectant, sterilizer, and biocide in various applications, including food processing, healthcare, and water treatment. PAA exhibits a broad spectrum of antimicrobial activity, effectively killing bacteria, viruses, fungi, and spores. Its effectiveness stems from its strong oxidizing properties, which disrupt the cell membranes and cellular processes of microorganisms. PAA is an environmentally friendly alternative to traditional disinfectants like chlorine, as it decomposes into non-toxic byproducts. Research into PAA focuses on understanding its mechanisms of action, optimizing its synthesis and stability, exploring its potential applications in new fields, and assessing its safety and environmental impact.'

Peracetic Acid: A liquid that functions as a strong oxidizing agent. It has an acrid odor and is used as a disinfectant. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

peracetic acid : A peroxy acid that is acetic acid in which the OH group is substituted by a hydroperoxy group. It is a versatile oxidising agent that is used as a disinfectant. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6585
CHEMBL ID444965
CHEBI ID42530
MeSH IDM0016248

Synonyms (107)

Synonym
AKOS015837803
ch3c(o)ooh
peracetic acid
f50 ,
ethaneperoxoic acid
D03467
79-21-0
acecide (tn)
acetyl hydroperoxide
acide peroxyacetique [french]
peroxoacetic acid
hsdb 1106
peroxyacetic acid
monoperacetic acid
estosteril
caswell no. 644
ccris 686
acido peroxiacetico [spanish]
ethaneperoxic acid
brn 1098464
einecs 201-186-8
desoxon 1
proxitane 4002
acetic peroxide
osbon ac
kyselina peroxyoctova [czech]
hydroperoxide, acetyl
epa pesticide chemical code 063201
peroxyacetic acid, >43% and with >6% hydrogen peroxide [forbidden]
acide peracetique [french]
NCGC00166305-01
bdbm50266095
CHEMBL444965 ,
dtxsid1025853 ,
dtxcid805853
cas-79-21-0
tox21_112402
ec 201-186-8
unii-i6kpi2e1hd
peroxyacetic acid, >43% and with >6% hydrogen peroxide
kyselina peroxyoctova
acide peracetique
acide peroxyacetique
i6kpi2e1hd ,
acido peroxiacetico
4-02-00-00390 (beilstein handbook reference)
proxitane 1507
oxypel
perethanoic acid
proxitane 12a
acecide
proxitane s
proxitane
lcap
peroxy-acetic acid
peracetic acid [who-dd]
peracetic acid [hsdb]
peracetic acid [mi]
peracetic acid [mart.]
ch3co2oh
per-acetic acid
acooh
KFSLWBXXFJQRDL-UHFFFAOYSA-N
peractic acid
peroxy acetic acid
CHEBI:42530 ,
peroxacetic acid
ethaneperoxoic acid, 9ci
acetic acid oxide
Q375140
DB14556
EN300-173399
weclean c2 tlcuo
acid, peroxyethanoic
oxymaster
gpes
tlcuo pure
clean works
care plus
sekusept steril
peroxyacetic acid (peracetic acid)
dr.vir germ peroxyacetic acid multi-disinfectant
tlcuo phytoncide
dialox
unicare
pu us phytoncide
peressigsaure
wofasteril e 400
ethanperoxsaure
bacteria zero premium
peroxyethansaure
bactipal
acid, peroxyacetic
pu us pure
usepa/opp pesticide code: 063201
joycare
blowhale deodorant senitizer
soproper
pu us lemon
tlcuo lemon
peroxyessigsaure
acido peracetico
peracetic acid (mart.)
peraflu d
acetic peroxid
acid, peracetic
peroxyethanoic acid

Research Excerpts

Overview

Peracetic acid (PAA) is a powerful oxidant with bactericidal and fungicidal properties. It is an alternative to traditional wastewater disinfection as it has a high oxidation potential without producing chlorinated disinfection byproducts.

ExcerptReferenceRelevance
"Peracetic acid (PAA) is a powerful oxidant with bactericidal and fungicidal properties."( Fogging With Peracetic Acid in Schools and Kindergartens.
Czupryna, P; Groth, M; Grześ, H; Kruszewska, E; Moniuszko-Malinowska, A; Pancewicz, S; Wondim, M, 2021
)
1.71
"Peracetic acid (PAA) is an alternative to traditional wastewater disinfection as it has a high oxidation potential without producing chlorinated disinfection byproducts. "( Selected Mechanistic Aspects of Viral Inactivation by Peracetic Acid.
Jacangelo, J; Schmitz, BW; Schwab, K; Wang, H, 2021
)
2.31
"Peracetic acid (PAA) serves as a potent and low-toxic oxidant for contaminant removal. "( Reduced Graphene Oxide Triggers Peracetic Acid Activation for Robust Removal of Micropollutants: The Role of Electron Transfer.
Fan, X; Kong, D; Li, J; Ma, J; Nan, J; Wang, X; Zhao, Y, 2022
)
2.45
"Peracetic acid (PAA) is a desirable disinfectant for municipal wastewater because of its potent disinfection performance and limited toxic by-products. "( Enhanced inactivation of Escherichia coli by ultrasound combined with peracetic acid during water disinfection.
Bai, Y; Chang, R; Hu, J; Hu, X; Peng, K; Shi, C; Xiang, P; Yang, C; Zhang, H; Zhang, Z; Zhou, Y, 2023
)
2.59
"Peracetic acid (PAA) is an emerging alternative disinfectant for saline waters; HOBr or HOCl is known as the sole species contributing to halogenation reactions during PAA oxidation and disinfection. "( Selective Transformation of Micropollutants in Saline Wastewater by Peracetic Acid: The Overlooked Brominating Agents.
Chen, J; Huang, CH; Li, N; Liu, T; Xiao, S; Xu, Y; Yin, W; Zhang, Y; Zhou, X, 2023
)
2.59
"Peracetic acid (PAA) is an alternative disinfectant for replacing chlorine-based oxidants in wastewater treatment, and the potential of PAA to induce a VBNC state in AR E."( Peracetic acid disinfection induces antibiotic-resistant E. coli into VBNC state but ineffectively eliminates the transmission potential of ARGs.
Chen, J; Li, N; Liu, T; Xu, Y; Yang, L; Yin, W; Zhang, L; Zhang, Y; Zhou, X, 2023
)
3.07
"Peracetic acid (PAA) is an oxidizer widely used for the sterilization of equipment in hospitals, pharmaceutical, cosmetic and food industries and also for water and wastewater disinfection. "( Peracetic acid: Structural elucidation for applications in wastewater treatment.
Carlos, TD; Cavallini, GS; da Silva, WP; Pereira, DH, 2020
)
3.44
"Peracetic acid (PAA) is an environmentally friendly disinfectant and oxidizer used in several water and wastewater treatment applications. "( Peracetic acid for conditioning of municipal wastewater sludge: Hygienization, odor control, and fertilizing properties.
Luukkonen, T; Pehkonen, SO; Prokkola, H, 2020
)
3.44
"Peracetic acid (PAA) is a strong oxidant with a redox potential higher than that of chlorine and does not form harmful disinfection by-products."( Optimising the measurement of peracetic acid to assess its degradation during drinking water disinfection.
Cao, C; Cen, C; San, Y; Zhang, K; Zhang, T; Zhou, X, 2020
)
1.57
"Peracetic acid (PAA) is a disinfection oxidant used in many industries including wastewater treatment. "( Oxidation of β-lactam antibiotics by peracetic acid: Reaction kinetics, product and pathway evaluation.
Cai, M; Du, P; Huang, CH; Sun, P; Zhang, K; Zhang, T; Zhou, X, 2017
)
2.17
"Peracetic acid (PAA) is an organic compound used efficiently as disinfectant in wastewater treatments. "( Defence strategies and antibiotic resistance gene abundance in enterococci under stress by exposure to low doses of peracetic acid.
Antonelli, M; Biavasco, F; Citterio, B; Colinas, N; Corno, G; Di Cesare, A; Eckert, EM; Fontaneto, D; Mangiaterra, G; Mauro, A; Sabatino, R; Turolla, A, 2017
)
2.11
"Peracetic acid (PAA) is a strong antimicrobial disinfectant that is expected to reduce the formation of HAAs and THMs during disinfection."( Evaluation of thirteen haloacetic acids and ten trihalomethanes formation by peracetic acid and chlorine drinking water disinfection.
Adams, CD; Eichholz, T; Hua, B; Inniss, EC; Ma, Y; Shi, H; Xue, R; Yang, J, 2017
)
1.41
"Peracetic acid (PAA) is a corrosive chemical with a pungent odor, which is extensively used in occupational settings and causes various health hazards in exposed workers. "( Description and evaluation of a peracetic acid air sampling and analysis method.
Kinsky, OR; Nordling, J; Osorio, M; Pechacek, N, 2017
)
2.18
"Peracetic acid (PAA) is a common oxidative sanitizer that is used in the food industry against various microorganisms. "( Molecular response of Vibrio parahaemolyticus to the sanitizer peracetic acid.
Hsu, P; Liao, R; Tang, CT; Wong, HC, 2018
)
2.16
"Peracetic acid (PAA) is an emerging disinfectant with a low disinfection by-product formation potential, but how PAA destroys gene function after killing bacteria remains to be studied. "( Higher functionality of bacterial plasmid DNA in water after peracetic acid disinfection compared with chlorination.
Brown, PJB; Hu, Z; Zhang, C, 2019
)
2.2
"Peracetic acid is an unspecific, pervasive oxidizer of C-C double bonds and reduced atoms."( Modes of action of three disinfectant active substances: a review.
Ingmer, H; Wessels, S, 2013
)
1.11
"Peracetic acid is a disinfectant agent with several favorable characteristics yet underutilized in Dentistry."( Influence of disinfection with peracetic acid and hypochlorite in dimensional alterations of casts obtained from addition silicone and polyether impressions.
Frizzera, F; Neves, AC; Peçanha, MM; Queiroz, DA; Silva-Concílio, LR; Tonetto, MR, 2013
)
1.4
"Peracetic acid (PAA) is a peroxide-based chemistry that is highly reactive and can produce strong local effects upon direct contact with the eyes, skin and respiratory tract. "( Evaluation of the toxicity data for peracetic acid in deriving occupational exposure limits: a minireview.
Caudill, J; Osorio, M; Pechacek, N; Peterson, B, 2015
)
2.13
"Peracetic acid (PAA) is a disinfectant considered for use in ballast water treatment, but its chemical behavior in such systems (i.e., saline waters) is largely unknown. "( Peracetic acid oxidation of saline waters in the absence and presence of H ₂O ₂: secondary oxidant and disinfection byproduct formation.
Höfer, T; Liu, ZQ; Salhi, E; Shah, AD; von Gunten, U, 2015
)
3.3
"Peracetic acid (PAA) is a therapeutic agent used for disinfection in aquaculture, but it must be investigated thoroughly in order to mitigate diseases without harming the fish. "( Growth inhibition of Aeromonas salmonicida and Yersinia ruckeri by disinfectants containing peracetic acid.
Behrens, S; Liu, D; Meinelt, T; Pedersen, LF; Phan, TM; Straus, DL; Wienke, A, 2015
)
2.08
"Peracetic acid (PAA) is a powerful disinfectant recently adopted as a therapeutic agent in aquaculture. "( Histological changes and antioxidant enzyme activity in signal crayfish (Pacifastacus leniusculus) associated with sub-acute peracetic acid exposure.
Chupani, L; Kouba, A; Stara, A; Velisek, J; Zuskova, E, 2016
)
2.08
"Peracetic acid (PAA) is an antimicrobial disinfectant used in agriculture, food processing, and medical facilities. "( Acute toxicity of peracetic acid (PAA) formulations to Ichthyophthirius multifiliis theronts.
Meinelt, T; Straus, DL, 2009
)
2.13
"Peracetic acid is an approved tuberculocide in hospital and domestic environments."( Toxicogenomic response of Mycobacterium bovis BCG to peracetic acid and a comparative analysis of the M. bovis BCG response to three oxidative disinfectants.
Bentley, WE; Jang, HJ; Nde, CW; Toghrol, F, 2011
)
1.34
"Peracetic acid (PAA) is a relatively new compound suggested for use to treat pathogens in aquaculture. "( Peracetic acid is effective for controlling fungus on channel catfish eggs.
Farmer, BD; Meinelt, T; Mitchell, AJ; Straus, DL, 2012
)
3.26
"Peracetic acid is a strong disinfectant with a wide spectrum of antimicrobial activity. "( Disinfection of wastewater with peracetic acid: a review.
Kitis, M, 2004
)
2.05
"Peracetic acid (PAA) is a disinfectant with a wide spectrum of antimicrobial activity, but little is known about the feasibility of using it in the field of drinking water treatment. "( [Disinfection efficiency of peracetic acid, alone and in combination with hypochlorite, against Mycobacterium avium in drinking water].
Brandi, G; De Santi, M; Schiavano, GF; Sisti, M,
)
1.87

Effects

Peracetic acid (PAA) has been approved as an antimicrobial for use in poultry chillers. It has been used to sterilize bone allografts without these disadvantages and does not impair the mechanical properties of soft tissue grafts in vitro. Peracetic Acid has quickly gained ground in water treatment over the last decade.

ExcerptReferenceRelevance
"Peracetic acid (PAA) has been widely used as an alternative disinfectant in wastewater treatment, and PAA-based advanced oxidation processes (AOPs) have drawn increasing attention recently. "( Hydrogen atom abstraction mechanism for organic compound oxidation by acetylperoxyl radical in Co(II)/peracetic acid activation system.
Chen, L; Du, P; Liu, W; Sun, G; Wang, J, 2022
)
2.38
"Peracetic acid has quickly gained ground in water treatment over the last decade. "( Formation of Halogenated Byproducts upon Water Treatment with Peracetic Acid.
Coha, M; Farinelli, G; Minella, M; Tiraferri, A; Vione, D, 2022
)
2.4
"Peracetic acid (PAA) has attracted growing attention as an alternative oxidant and disinfectant in wastewater treatment due to the increased demand to reduce chlorine usage and control disinfection byproducts (DBPs). "( Peracetic acid-based advanced oxidation processes for decontamination and disinfection of water: A review.
Ao, XW; Eloranta, J; Huang, CH; Li, C; Lu, ZD; Santoro, D; Sun, WJ, 2021
)
3.51
"Peracetic acid (PAA) has gained increasing attention over the last decades as a suitable and environmentally-friendly alternative to chlorine-based compounds for wastewater disinfection, claiming limited disinfection by-products (DBPs) formed and no persistent residues in the environment. "( Disinfection by-products formation and ecotoxicological effects of effluents treated with peracetic acid: A review.
Antonelli, M; Domínguez Henao, L; Turolla, A, 2018
)
2.14
"Peracetic acid (PAA) has been used to sterilize biomaterial scaffolds and allografts before their implantation. "( Keratinocyte Cytotoxicity of Peracetic Acid Used as Sterilizing Agent for Implant Scaffolds.
Arthur, RA; Kapczinski, MP; Lamers, ML; Mengatto, CM; Soto, AF, 2019
)
2.25
"Peracetic acid has been used for sterilization following the protocol recommended by the manufacturer."( Surgical infection in a videolaparoscopic cholecystectomy when using peracetic acid for the sterilization of instruments.
Andreto, LM; de Mello, MJ; de Melo, EM; Leão, Cde S,
)
1.09
"Peracetic acid solution has pulp tissue dissolution. "( Influence of Concentration and Agitation of Sodium Hypochlorite and Peracetic Acid Solutions on Tissue Dissolution.
Guerreiro-Tanomaru, JM; Martelo, RB; Silveira, BR; Tanomaru-Filho, M, 2015
)
2.1
"Peracetic acid (PAA) has been approved as an antimicrobial for use in poultry chillers."( The microbial and quality properties of poultry carcasses treated with peracetic acid as an antimicrobial treatment.
Bauermeister, LJ; Bowers, JW; McKee, SR; Townsend, JC, 2008
)
1.3
"Peracetic acid (PAA) has been selectively electroanalyzed in the presence of a large excess of hydrogen peroxide (H(2)O(2)), about 500 fold that of PAA, using Au (111)-like gold electrode in acetate buffer solutions of pH 5.4. "( Selective electronalysis of peracetic acid in the presence of a large excess of H2O2 at Au(111)-like gold electrode.
Awad, MI, 2012
)
2.12
"Peracetic acid (PAA) has been successfully used to sterilize bone allografts without these disadvantages and does not impair the mechanical properties of soft tissue grafts in vitro."( Remodeling of ACL allografts is inhibited by peracetic acid sterilization.
Gonnermann, J; Kamp, J; Pruss, A; Przybilla, D; Scheffler, SU, 2008
)
1.33

Actions

ExcerptReferenceRelevance
"Only peracetic acid could inactivate high-titer suspensions of phages in a short time."( Characterization of a new virulent phage (MLC-A) of Lactobacillus paracasei.
Ackermann, HW; Capra, ML; Del L Quiberoni, A; Moineau, S; Reinheimer, JA, 2006
)
0.79

Treatment

Peracetic acid-ethanol (PE) treatment has been proven reliable and effective for disinfection of human bone allografts. Treatment of acellularized tendon scaffolds increases matrix porosity, leading to greater reseeding.

ExcerptReferenceRelevance
"Peracetic acid (PAA) pretreatment is considered as a novel and effective chemical pretreatment method for sludge. "( Peracetic acid pretreatment improves biogas production from anaerobic digestion of sewage sludge by promoting organic matter release, conversion and affecting microbial community.
Li, H; Li, S; Liu, X; Ren, W; Zhai, Y; Zhang, Y, 2024
)
4.33
"Peracetic acid-ethanol (PE) treatment has been proven reliable and effective for disinfection of human bone allografts."( Comparative biomechanical and microstructural analysis of native versus peracetic acid-ethanol treated cancellous bone graft.
Baas, J; Despang, F; Gelinsky, M; Günther, KP; Liebers, C; Pruss, A; Rauh, J; Stiehler, M, 2014
)
1.36
"Peracetic acid treatment of acellularized tendon scaffolds increases matrix porosity, leading to greater reseeding. "( Optimization of human tendon tissue engineering: peracetic acid oxidation for enhanced reseeding of acellularized intrasynovial tendon.
Bari, S; Chang, J; Kraus, A; Pham, H; Pridgen, BC; Woon, CYL, 2011
)
2.07
"Peracetic acid (PAA) pretreatment seemed to be the most effective for improving enzymatic saccharification of the weed stem in the three chemical pretreatment methods under the same conditions."( Comparative study on chemical pretreatment methods for improving enzymatic digestibility of crofton weed stem.
Liu, D; Zhang, L; Zhao, X, 2008
)
1.07

Toxicity

Study looked at bile in Cyprinus carpio exposed for 20 d to lake water treated with 3 different disinfectants. Treatment of porcine small intestine with a peracetic acid/ethanol solution leads to a virus-free, non-crosslinked biomaterial safe for xenotransplantation into humans.

ExcerptReferenceRelevance
" Identification of hazards and critical control points associated with water recycling, biomass management, use of multifunctional equipment, and possible concentration of toxic substances in the closed system is essential for the development of safe food processing techniques and equipment."( Food safety and sanitation during an extended mission.
Hentges, DL, 1999
)
0.3
" These results demonstrate that treatment of porcine small intestine with a peracetic acid/ethanol solution leads to a virus-free, non-crosslinked biomaterial safe for xenotransplantation into humans."( Virus safety of a porcine-derived medical device: evaluation of a viral inactivation method.
Hiles, M; Hodde, J, 2002
)
0.54
"Two percent glutaraldehyde has been the reference disinfectant for high-level disinfection, but its frequent association with adverse effects has stimulated a search for newer disinfectants."( Comparison of the disinfectant efficacy of Perasafe and 2% glutaraldehyde in in vitro tests.
Fernandez-Aceñero, MJ; Herruzo-Cabrera, R; Vizcaino-Alcaide, MJ, 2003
)
0.32
"This study was prompted by toxic responses to disinfecting agents reported in patients after surgical procedures and in sensitized health care personnel."( Cytotoxicity of liquid disinfectants.
Bonifacino, A; Sagripanti, JL, 2000
)
0.31
" By comparing this value with peracetic acid concentrations detected in effluents from a pilot plant it is expected that treated wastewater would show acute toxic effects on aquatic organisms."( [Genotoxic and ecotoxic effects of urban waste water disinfected with sodium hypochlorite or peracetic acid].
Conti, L; Crebelli, R; Cutilli, D; Feretti, D; Marchini, S; Monarca, S; Ottaviani, M; Veschetti, E; Zani, C; Zerbini, I,
)
0.64
" The surface-water extracts were very often toxic to most of the test organisms considered, partially masking their potential mutagenic activity."( In vitro potential genotoxic effects of surface drinking water treated with chlorine and alternative disinfectants.
Buschini, A; Feretti, D; Guzzella, L; Monarca, S; Poli, P; Richardson, SD; Rossi, C; Zani, C; Zerbini, I, 2004
)
0.32
"This study evaluates the effects of disinfection on the formation of toxic compounds in lake water treated with sodium hypochlorite, chlorine dioxide and peracetic acid (a disinfectant not previously used in drinking water processes)."( Study of potential toxic effects on rainbow trout hepatocytes of surface water treated with chlorine or alternative disinfectants.
Chiesara, E; Ferraris, M; Frigerio, S; Fumagalli, R; Giovara, A; Marabini, L; Radice, S, 2005
)
0.53
" The exposure to chlorine disinfectants without the addition of HA produced a clear toxic effect."( Modulating effects of humic acids on genotoxicity induced by water disinfectants in Cyprinus carpio.
Buschini, A; Gustavino, B; Monfrinotti, M; Poli, P; Rizzoni, M; Rossi, C; Tancioni, L, 2005
)
0.33
"A sensitive and rapid method to evaluate toxic and genotoxic properties of drinking water supplied from Lake Trasimeno (Umbria, Central Italy) was worked out analysing bile in Cyprinus carpio exposed for 20 d to lake water treated with 3 different disinfectants, sodium hypochlorite (NaClO), chlorine dioxide (ClO(2)) and peracetic acid (PAA)."( A protocol for the evaluation of genotoxicity in bile of carp (Cyprinus carpio) exposed to lake water treated with different disinfectants.
Dominici, L; Dörr, AJ; Elia, AC; Fatigoni, C; Monarca, S; Moretti, M; Villarini, M, 2011
)
0.54
"The toxic potential of four disinfectant agents (chlorine, ozone, peracetic acid and UV radiation), used in the disinfection of urban wastewater, was evaluated with respect to four aquatic organisms."( Toxicity on aquatic organisms exposed to secondary effluent disinfected with chlorine, peracetic acid, ozone and UV radiation.
da Costa, JB; Daniel, LA; Espíndola, EL; Rodgher, S, 2014
)
0.86
" However, little information was available about whether ICM-derived DBPs are toxic to aquatic organisms."( Disinfection byproducts of iopamidol, iohexol, diatrizoate and their distinct acute toxicity on Scenedesmus sp., Daphnia magna and Danio rerio.
Liu, H; Watson, P; Yang, F; Yang, X; Zhou, N, 2023
)
0.91

Compound-Compound Interactions

Peracetic acid-ethanol in combination with low-dose gamma irradiation (PE-R) would inactivate potential deleterious microorganisms without affecting mechanical and biocompatible properties of tendon allograft. Ultrasound was used to reach the sterilizing effect during the treatment of metal surgical appliances packed in a row.

ExcerptReferenceRelevance
" The efficiency and stability of Persteril solution in combination with the detergents were similar to those of Persteril aqueous solution."( Disinfectant effect of Persteril in combination with detergents.
Melichercíková, V, 1989
)
0.28
"25-0 unit was used to reach the sterilizing effect during the treatment of metal surgical appliances packed in a row by means of ultrasound combined with 6% hydrogen peroxide (40 degrees C) for 60 minutes and with 1% (according to peracetic acid) desoxone-1 (18 degrees C) for 45 minutes."( [Possibilities of sterilization of medical equipment using ultrasonics combined with disinfectants and sterilizing agents].
Epshteĭn, AE; Evtikova, LV; Me'lnikova, GN; Polosina, IuA; Ramkova, NV,
)
0.31
" The aim of this study was to evaluate the effects of different incubation times of water, hydrogen peroxide and alcohol cleansing procedures combined with PES on biomechanical properties of freeze-dried cortical bone."( The effect of chemical cleansing procedures combined with peracetic acid-ethanol sterilization on biomechanical properties of cortical bone.
Haimi, S; Hirn, M; Pelto, M; Suuronen, R; Vienonen, A; Virtanen, V, 2008
)
0.59
"Peracetic acid-ethanol in combination with low-dose gamma irradiation (PE-R) would inactivate potential deleterious microorganisms without affecting mechanical and biocompatible properties of tendon allograft."( Tendon allograft sterilized by peracetic acid/ethanol combined with gamma irradiation.
Li, B; Li, Y; Liu, X; Wang, X; Zhang, N; Zhang, Y; Zhou, M, 2014
)
2.13
" This study explored the efficiency and mechanism of Escherichia coli inactivation by PAA combined with ultrasound simultaneously (ultrasound + PAA) or (ultrasound → PAA) sequentially."( Enhanced inactivation of Escherichia coli by ultrasound combined with peracetic acid during water disinfection.
Bai, Y; Chang, R; Hu, J; Hu, X; Peng, K; Shi, C; Xiang, P; Yang, C; Zhang, H; Zhang, Z; Zhou, Y, 2023
)
1.14

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" The mutagenic activity for each compound determined from the dose-response relationship gave values ranging from 250 (PBN) to 6,500 (PBzN) revertants/mumols."( Comparison of mutagenic activities of several peroxyacyl nitrates.
Bufalini, JJ; Claxton, LD; Cupitt, LT; Hudgens, EE; Kleindienst, TE; Nero, CM; Shepson, PB; Smith, DF, 1990
)
0.28
" Despite the very high dosage as it will never be demanded in therapeutical measures, the mucosal tissues under study neither showed inflammations nor scar formation after 12 months of administration."( Action of chronic peracetic acid (wofasteril) administration on the rabbit oral mucosa, vaginal mucosa, and skin.
Hörold, J; Juretzek, U; Müller, P; Raabe, G, 1988
)
0.61
" Although the RF were higher in the virucidal tests, the time-dependent dose-response curves for the epitope and genome alteration and for the infectivity inactivation followed the same inactivation kinetics."( Molecular approaches to validate disinfectants against human hepatitis B virus.
Gerlich, WH; Glebe, D; Jursch, CA; Marie, O; Schaefer, S; Thraenhart, O, 2002
)
0.31
"15% dosage and 5 days of treatment."( The potential for disinfection of separated faecal matter by urea and by peracetic acid for hygienic nutrient recycling.
Albihn, A; Bagge, E; Holmqvist, A; Jönsson, H; Vinnerås, B, 2003
)
0.55
" The quantitative dosage of HP by spectrophotometry confirmed the permeation risk inside all pumps except the Surefuser."( Permeation risks with peracetic acid and hydrogen peroxide sterilizing agent inside ambulatory pumps.
Amandine, G; Bourguignon, C; Celine, B; Grain, A; Joel, S; Norbert, V; Schlatter, J; Vermerie, N,
)
0.45
" temperature, pH and organic load of the water could possibly influence the efficiency of the PAA application and should therefore be taken into account while picking the dosage and length of the PAA exposure."( [Antiparasitic effects of peracetic acid (PAA) against infective stages (theronts) of white spot disease, Ichthyophthirius multifiliis in vitro].
Bräunig, I; Meinelt, T; Staaks, G; Staaks, J; Stüber, A, 2007
)
0.64
" Results from six toxicological tests revealed very steep dose-response curves of the treatment."( Effectiveness and potential toxicological impact of the PERACLEAN Ocean ballast water treatment technology.
de Lafontaine, Y; Despatie, SP; Wiley, C, 2008
)
0.35
" For this purpose, resistance after 4 and 11-days of biofilm formation was quantified in terms of lethal dose 90% values (LD(90)), determined according with a dose-response logistic mathematical model."( Resistance to benzalkonium chloride, peracetic acid and nisin during formation of mature biofilms by Listeria monocytogenes.
Cabo, ML; Herrera, JJ; Saá Ibusquiza, P, 2011
)
0.64
" The only condition that produced a disinfection efficiency of approximately 5 logs, when both disinfection agents were used together, was the combined process dosing 30 mg PAA/L at a pilot plant flow of 21 L/min and contact time of 10 minutes to attain an average C(t) x t product of 24."( Disinfection of an advanced primary effluent with peracetic acid and ultraviolet combined treatment: a continuous-flow pilot plant study.
Gehr, R; González, A; López, R; Vaca, M, 2012
)
0.63
" Both treatments produced bacterial inactivation in a dose-response fashion."( ERIC-PCR technique applied to monitoring and quantification of DNA damage during water disinfection process.
Brandi, RJ; Cristiani, M; Flores, MJ; Labas, MD; Tedeschi, FA; Zalazar, FE, 2020
)
0.56
" 80% DCF was removed at mild condition (pH 6-7) within 60 s, and its removal rate could be enhanced with the increase in Fe(II) dosage and PAA concentration."( Degradation of diclofenac by Fe(II)-activated peracetic acid.
Fu, Y; Liu, Y; Shi, H; Wang, S; Wang, Z, 2021
)
0.88
" Low dosage of UV/PAA can effectively control fouling by enhancing the degradation of dissolved organics."( Mechanism study on the effect of peracetic acid (PAA), UV/PAA and ultrasonic/PAA oxidation on ultrafiltration performance during algae-laden water treatment.
Liu, B; Zhu, T, 2022
)
1
" coli concentration and the impact of effluent quality and PAA dosage on PAA decay kinetics."( Disinfection efficiency prediction under dynamic conditions: Application to peracetic acid disinfection of wastewater.
Antonelli, M; Bianchi, GF; Foschi, J; Turolla, A, 2022
)
0.95
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
oxidising agentA substance that removes electrons from another reactant in a redox reaction.
disinfectantAn antimicrobial agent that is applied to non-living objects to destroy harmful microorganisms or to inhibit their activity.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
a peroxy acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency2.68320.000214.376460.0339AID720691
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)Ki17,000.00000.19004.83279.6000AID392093
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (27)

Processvia Protein(s)Taxonomy
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (12)

Processvia Protein(s)Taxonomy
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID392095Inactivation of PTP1B at 15 uM after 15 sec in presence of phosphate ion2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Oxidative inactivation of protein tyrosine phosphatase 1B by organic hydroperoxides.
AID392096Inactivation of PTP1B assessed as return of enzyme activity at 5 uM after 10 mins in presence of dithiothreitol2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Oxidative inactivation of protein tyrosine phosphatase 1B by organic hydroperoxides.
AID392094Inactivation of PTP1B at 15 uM after 15 sec2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Oxidative inactivation of protein tyrosine phosphatase 1B by organic hydroperoxides.
AID392098Inactivation of PTP1B assessed as return of enzyme activity at 800 nM for 10 mins in presence of dithiothreitol2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Oxidative inactivation of protein tyrosine phosphatase 1B by organic hydroperoxides.
AID392093Inhibition of PTP1B2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Oxidative inactivation of protein tyrosine phosphatase 1B by organic hydroperoxides.
AID392092Inactivation of PTP1B at 15 uM after 15 sec in presence of glutathione2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Oxidative inactivation of protein tyrosine phosphatase 1B by organic hydroperoxides.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,150)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990177 (15.39)18.7374
1990's115 (10.00)18.2507
2000's279 (24.26)29.6817
2010's349 (30.35)24.3611
2020's230 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.15 (24.57)
Research Supply Index7.11 (2.92)
Research Growth Index4.84 (4.65)
Search Engine Demand Index137.17 (26.88)
Search Engine Supply Index3.06 (0.95)

This Compound (53.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials13 (1.08%)5.53%
Reviews29 (2.40%)6.00%
Case Studies9 (0.75%)4.05%
Observational1 (0.08%)0.25%
Other1,154 (95.69%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]